Using hematopoietic lineages as a paradigm, scientists leveraged the extraordinary molecular diversity of heparan sulfate glycans to establish cellular “glycotypes” by utilizing a panel of anti-HS single-chain variable fragment antibodies.
[Journal of Experimental Medicine]